Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Qol and Patients' Care

Sexual function 1-year after allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation volume 51, pages 833–840 (2016)Cite this article

Subjects

Abstract

Treatment with allogeneic hematopoietic stem cell transplantation (HSCT) is associated with short and long-term toxicities that can result in alterations in sexual functioning. The aims of this prospective evaluation were to determine: (1) associations between HSCT and increased sexual dysfunction 1 year after treatment; and (2) associations between sexual dysfunction, body image, anxiety and depression. This controlled prospective cohort study was conducted from October 2010 to November 2013. Patients completed assessments 2–3 weeks before HSCT (N=124) and 1 year after treatment (N=63). Assessment included descriptive data, Sexual Functioning Questionnaire, Body Image Scale and Hospital Anxiety and Depression Scale. The results showed a significant decline in overall sexual function in both men and women (P=<0.001, P=0.010, respectively), although men generally scored higher than women. Forty-seven percent of men and 60% of women reported at least one physical sexual problem 1 year after HSCT. Patients with chronic GVHD trended toward reporting lower levels of sexual function. Finally, women with chronic GVHD scored lower than those without chronic GVHD on the sexual function problem subscale (P=0.008). Sexual dysfunction remains a major problem for men and women 1 year after HSCT and requires routine evaluation and treatment after HSCT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Apperley J, Carreras E, Gluckman E, Masszi T The 2012 revised edition of the EBMT-ESH Handbook on Haemopoietic Stem Cell Transplantation. Chugai Sanofi Aventis, 2012.

  2. Watson M, Wheatley K, Harrison GA, Zittoun R, Gray RG, Goldstone AH et al. Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial. Cancer 1999; 86: 1231–1239.

    Article  CAS  Google Scholar 

  3. Humphreys CT, Tallman B, Altmaier EM, Barnette V . Sexual functioning in patients undergoing bone marrow transplantation: a longitudinal study. Bone Marrow Transplant 2007; 39: 491–496.

    Article  CAS  Google Scholar 

  4. Syrjala KL, Kurland BF, Abrams JR, Sanders JE, Heiman JR . Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years. Blood 2008; 111: 989–996.

    Article  CAS  Google Scholar 

  5. Syrjala KL, Langer SL, Abrams JR, Storer BE, Martin PJ . Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol 2005; 23: 6596–6606.

    Article  Google Scholar 

  6. Socie G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999; 341: 14–21.

    Article  CAS  Google Scholar 

  7. Tierney DK . Sexuality following hematopoietic cell transplantation. Clin J Oncol Nurs 2004; 8: 43–47.

    PubMed  Google Scholar 

  8. Syrjala KL, Roth-Roemer SL, Abrams JR, Scanlan JM, Chapko MK, Visser S et al. Prevalence and predictors of sexual dysfunction in long-term survivors of marrow transplantation. J Clin Oncol 1998; 16: 3148–3157.

    Article  CAS  Google Scholar 

  9. Yi JC, Syrjala KL . Sexuality after hematopoietic stem cell transplantation. Cancer J 2009; 15: 57–64.

    Article  Google Scholar 

  10. Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN . Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psychooncology 2009; 18: 113–127.

    Article  Google Scholar 

  11. Sanders JE . Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation. Int J Hematol 2002; 76: 15–28.

    Article  Google Scholar 

  12. Hirsch P, Leclerc M, Rybojad M, Petropoulou AD, Robin M, Ribaud P et al. Female genital chronic graft-versus-host disease: importance of early diagnosis to avoid severe complications. Transplantation 2012; 93: 1265–1269.

    Article  Google Scholar 

  13. Passweg JR, Baldomero H, Bregni M, Cesaro S, Dreger P, Duarte RF et al. Hematopoietic SCT in Europe: data and trends in 2011. Bone Marrow Transplant 2013; 48: 1161–1167.

    Article  CAS  Google Scholar 

  14. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.

    Article  Google Scholar 

  15. Mattson MR . Graft-versus-host disease: review and nursing implications. Clin J Oncol Nurs 2007; 11: 325–328.

    Article  Google Scholar 

  16. Abou-Mourad YR, Lau BC, Barnett MJ, Forrest DL, Hogge DE, Nantel SH et al. Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens. Bone Marrow Transplant 2010; 45: 295–302.

    Article  CAS  Google Scholar 

  17. Zantomio D, Grigg AP, MacGregor L, Panek-Hudson Y, Szer J, Ayton R . Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management. Bone Marrow Transplant 2006; 38: 567–572.

    Article  CAS  Google Scholar 

  18. Lara LA, De Andrade JM, Mauad LM, Ferrarese SR, Marana HR, Tiezzi DG et al. Genital manifestation of graft-vs.-host disease: a series of case reports. J Sex Med 2010; 7: 3216–3225.

    Article  Google Scholar 

  19. Mueller SM, Haeusermann P, Rovo A, Halter JP, Passweg J, Itin P et al. Genital chronic GVHD in men after hematopoietic stem cell transplantation: a single-center cross-sectional analysis of 155 patients. Biol Blood Marrow Transplant 2013; 19: 1574–1580.

    Article  Google Scholar 

  20. Smith Knutsson E, Bjork Y, Broman AK, Helstrom L, Levin Jakobsen AM, Nilsson O et al. Genital chronic graft-versus-host disease in females: a cross-sectional study. Biol Blood Marrow Transplant 2014; 20: 806–811.

    Article  Google Scholar 

  21. Bruner DW, Calvano T . The sexual impact of cancer and cancer treatments in men. Nurs Clin North Am 2007; 42: 555–580.

    Article  Google Scholar 

  22. Barton-Burke M, Gustason CJ . Sexuality in women with cancer. Nurs Clin North Am 2007; 42: 531–554.

    Article  Google Scholar 

  23. Weber CS, Fliege H, Arck PC, Kreuzer KA, Rose M, Klapp BF . Patients with haematological malignancies show a restricted body image focusing on function and emotion. Eur J Cancer Care (Engl) 2005; 14: 155–165.

    Article  CAS  Google Scholar 

  24. Thygesen KH, Schjodt I, Jarden M . The impact of hematopoietic stem cell transplantation on sexuality: a systematic review of the literature. Bone Marrow Transplant 2012; 47: 716–724.

    Article  CAS  Google Scholar 

  25. Syrjala KL, Schroeder TC, Abrams JR, Atkins TZ, Brown WS, Sanders JE et al. Sexual function measurement and outcomes in cancer survivors and matched controls. J Sex Res 2000; 37: 213–225.

    Article  Google Scholar 

  26. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 2005; 8: 94–104.

    Article  Google Scholar 

  27. Hopwood P, Fletcher I, Lee A, Al Ghazal S . A body image scale for use with cancer patients. Eur J Cancer 2001; 37: 189–197.

    Article  CAS  Google Scholar 

  28. Snaith RP, Zigmond AS . The hospital anxiety and depression scale. Br Med J (Clin Res Ed) 1986; 292: 344.

    Article  CAS  Google Scholar 

  29. Derogatis LR, Burnett AL . The epidemiology of sexual dysfunctions. J Sex Med 2008; 5: 289–300.

    Article  Google Scholar 

  30. Christensen BS, Gronbaek M, Osler M, Pedersen BV, Graugaard C, Frisch M . Sexual dysfunctions and difficulties in Denmark: prevalence and associated sociodemographic factors. Arch Sex Behav 2011; 40: 121–132.

    Article  Google Scholar 

  31. Christensen BS, Gronbaek M, Osler M, Pedersen BV, Graugaard C, Frisch M . Associations between physical and mental health problems and sexual dysfunctions in sexually active Danes. J Sex Med 2011; 8: 1890–1902.

    Article  Google Scholar 

  32. Marks DI, Friedman SH, Delli Carpini L, Nezu CM, Nezu AM . A prospective study of the effects of high-dose chemotherapy and bone marrow transplantation on sexual function in the first year after transplant. Bone Marrow Transplant 1997; 19: 819–822.

    Article  CAS  Google Scholar 

  33. Molassiotis A, van den Akker OB, Milligan DW, Goldman JM, Boughton BJ, Holmes JA et al. Quality of life in long-term survivors of marrow transplantation: comparison with a matched group receiving maintenance chemotherapy. Bone Marrow Transplant 1996; 17: 249–258.

    CAS  PubMed  Google Scholar 

  34. Gruber U, Fegg M, Buchmann M, Kolb HJ, Hiddemann W . The long-term psychosocial effects of haematopoetic stem cell transplantation. Eur J Cancer Care (Engl) 2003; 12: 249–256.

    CAS  Google Scholar 

  35. Park ER, Norris RL, Bober SL . Sexual health communication during cancer care: barriers and recommendations. Cancer J 2009; 15: 74–77.

    Article  Google Scholar 

  36. McKee AL Jr, Schover LR . Sexuality rehabilitation. Cancer 2001; 92: 1008–1012.

    Article  Google Scholar 

Download references

Acknowledgements

We thank the dedicated transplant respondents who have participated in this study. This work was supported by grants from The Novo Nordic Foundation.

Author information

Authors and Affiliations

  1. Department of Hematology, Bone Marrow Transplantation Unit, Rigshospitalet University Hospital, Copenhagen University Hospital, Copenhagen, Denmark

    K H Noerskov

  2. Department of Hematology, Bone Marrow Transplantation Unit, Rigshospitalet University Hospital, Copenhagen University Hospital, Copenhagen, Denmark

    I Schjødt

  3. Fred Hutchinson Cancer Research Center,, Seattle, WA, USA

    K L Syrjala

  4. The University Hospitals Center for Health Research (UCSF), Copenhagen University Hospital and Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark

    M Jarden

Authors
  1. K H Noerskov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I Schjødt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K L Syrjala
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Jarden
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K H Noerskov.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on Bone Marrow Transplantation website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Noerskov, K., Schjødt, I., Syrjala, K. et al. Sexual function 1-year after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 51, 833–840 (2016). https://doi.org/10.1038/bmt.2015.342

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2015.342

This article is cited by

Search

Advanced search

Quick links